Engineers Gate Manager’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Engineers Gate Manager’s Portfolio RETA Stock Details RETA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-11,569	Closed	-$440K	–	2113
2022 Q4	$440K	Buy	+11,569	New	+$398K	0.03%	978
2022 Q3	–	Sell	-22,877	Closed	-$695K	–	2195
2022 Q2	$695K	Sell	22,877 -3,847	-14%	-$115K	0.03%	918
2022 Q1	$875K	Buy	26,724 +1,596	+6%	+$47.4K	0.03%	748
2021 Q4	$663K	Buy	+25,128	New	+$1.94M	0.03%	863
2020 Q2	–	Sell	-8,647	Closed	-$1.25M	–	2048
2020 Q1	$1.25M	Buy	+8,647	New	+$1.67M	0.09%	337
2019 Q1	–	Sell	-23,727	Closed	-$1.33M	–	1211
2018 Q4	$1.33M	Sell	23,727 -16,387	-41%	-$1M	0.11%	290
2018 Q3	$3.28M	Buy	40,114 +16,071	+67%	+$1.13M	0.25%	115
2018 Q2	$841K	Buy	+24,043	New	+$732K	0.07%	410

Other funds holding RETA

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Engineers Gate Manager's RETA Position: Q1 2023 in Review

Engineers Gate Manager sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q1 2023, closing a stake of 11,569 shares — an estimated $440K sold.

Engineers Gate Manager first reported a position in RETA in Q2 2018 and held it in 8 quarters. The position peaked at $3.28M in Q3 2018. 205 funds tracked by Wall St. Rank hold RETA as of Q1 2023.

Engineers Gate Manager reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
Engineers Gate Manager sold 11,569 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q1 2023, an estimated $440K.
Engineers Gate Manager first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q2 2018 and held it in 8 quarters.
Engineers Gate Manager's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $3.28M in Q3 2018.
205 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q1 2023.

Based on Engineers Gate Manager's 13F filing for Q1 2023, filed 15 May 2023.